Sales and Marketing

Showing 15 posts of 11527 posts found.

$10 generic Solvaldi emerges in Bangladesh

March 10, 2015 Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi

A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015 Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

Apple highlights ‘ResearchKit’ through watch launch

March 10, 2015 Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables

US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …

Oncologists say CDF cuts will compromise treatment

March 10, 2015 Sales and Marketing CDF, Jevtana, NHS, NICE, Sanofi, cabazitaxel, doctors.net, m3

Oncologists believe cutting drugs from the Cancer Drugs Fund won’t save the NHS money and will worsen patient outcomes according …

Sanofi names audit committee chairman

March 10, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi

Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …

Targacept and Catalyst sign $100 million deal

March 9, 2015 Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences

Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …

Novo Nordisk obesity drug shows added benefits

March 9, 2015 Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight

New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …

FDA approves new anti-fungal treatment

March 9, 2015 Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis

The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

ESSA Pharma appoints independent director

March 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger

US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …

Merck and NewLink Ebola vaccine trial begins

March 6, 2015 Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …

Novartis secures first US biosimilar product

March 6, 2015 Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …

Merck and Eisai partner on cancer therapy trial

March 6, 2015 Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …

FDA launches drug shortages app

March 6, 2015 Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages

The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …

Anti-blood clotting drug Eliquis gets NICE nod

March 6, 2015 Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting

Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …
The Gateway to Local Adoption Series

Latest content